UA94717C2 - Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины - Google Patents
Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакциныInfo
- Publication number
- UA94717C2 UA94717C2 UAA200802674A UAA200802674A UA94717C2 UA 94717 C2 UA94717 C2 UA 94717C2 UA A200802674 A UAA200802674 A UA A200802674A UA A200802674 A UAA200802674 A UA A200802674A UA 94717 C2 UA94717 C2 UA 94717C2
- Authority
- UA
- Ukraine
- Prior art keywords
- influenza virus
- molecule
- monitoring
- modified influenza
- vaccine efficiency
- Prior art date
Links
- 241000712461 unidentified influenza virus Species 0.000 title abstract 6
- 238000012544 monitoring process Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 101710154606 Hemagglutinin Proteins 0.000 abstract 9
- 101710093908 Outer capsid protein VP4 Proteins 0.000 abstract 9
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 abstract 9
- 101710176177 Protein A56 Proteins 0.000 abstract 9
- 239000000185 hemagglutinin Substances 0.000 abstract 9
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 2
- 229960001230 asparagine Drugs 0.000 abstract 2
- 235000009582 asparagine Nutrition 0.000 abstract 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 abstract 1
- 229960003971 influenza vaccine Drugs 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
Изобретение относится к молекуле гемагглютинина (НА) вируса гриппа, который содержит аспарагин в аминокислотном положении, который соответствует аминокислотному положению 223 в НА Н5, где молекула НА не происходит от изолята человеческого Н5 А/НК/213/03 и где включение аспарагина в положение 223 приводит к повышенной реактивности относительно антисыворотки, полученной из организма животного, которое инфицировано вирусом гриппа или противогриппозной вакциной. Также изобретение относится к рекомбинантному вирусу гриппа, который содержит заявленную молекулу НА вируса гриппа и вакцинного вируса гриппа, который содержит заявленную рекомбинантную молекулу гемаглютинина (НА), а также изобретение относится к противогриппозной вакцине, которая содержит заявленную молекулу гемаглютинина вируса гриппа.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70580805P | 2005-08-04 | 2005-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94717C2 true UA94717C2 (ru) | 2011-06-10 |
Family
ID=37727844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200802674A UA94717C2 (ru) | 2005-08-04 | 2006-07-28 | Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины |
Country Status (16)
Country | Link |
---|---|
US (4) | US7871626B2 (ru) |
EP (1) | EP1924281B1 (ru) |
JP (2) | JP5395430B2 (ru) |
KR (1) | KR101334047B1 (ru) |
CN (2) | CN103172710B (ru) |
AU (1) | AU2006278696B2 (ru) |
BR (1) | BRPI0614297A2 (ru) |
CA (1) | CA2617483C (ru) |
ES (1) | ES2728791T3 (ru) |
HU (1) | HUE043952T2 (ru) |
PL (1) | PL1924281T3 (ru) |
RU (3) | RU2480480C2 (ru) |
SG (1) | SG2014007934A (ru) |
UA (1) | UA94717C2 (ru) |
WO (1) | WO2007019094A2 (ru) |
ZA (1) | ZA200800505B (ru) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
EP1942924B1 (en) | 2005-10-28 | 2012-02-01 | Boehringer Ingelheim Vetmedica GmbH | Use of vaccines for the treatment/prevention of the transmission of influenza pathogens between species |
WO2008021415A2 (en) * | 2006-08-14 | 2008-02-21 | Massachusetts Institute Of Technology | Glycan data mining system |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
JP5597128B2 (ja) * | 2007-05-11 | 2014-10-01 | テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド | H5トリインフルエンザの診断および監視に有用なh5亜型特異的結合タンパク質 |
KR101660363B1 (ko) * | 2007-06-25 | 2016-09-28 | 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 | 인플루엔자를 억제하는 조성물 및 방법 |
CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
NZ587108A (en) | 2007-11-27 | 2013-04-26 | Medicago Inc | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
JP5569944B2 (ja) * | 2008-04-01 | 2014-08-13 | イネイト・イムノセラピューティクス・リミテッド | 抗感染薬およびその使用 |
ES2593277T3 (es) * | 2008-07-18 | 2016-12-07 | Medicago Inc. | Nuevo epítopo de inmunización contra el virus de la influenza |
DK2358386T3 (en) * | 2008-11-28 | 2017-02-13 | Statens Seruminstitut | Optimized flu vaccine |
KR101145720B1 (ko) * | 2009-06-23 | 2012-05-14 | 한밭대학교 산학협력단 | 안전성이 뛰어난 인플루엔자 바이러스 백신용 재조합 헤마글루티닌 단백질을 함유하는 생분해성 plga 미립자의 제조 방법 |
MY182643A (en) | 2009-06-24 | 2021-01-27 | Medicago Inc | Chimeric influenza virus-like particles comprising hemagglutinin |
WO2010151673A1 (en) * | 2009-06-25 | 2010-12-29 | Medimmune, Llc | Swine influenza hemagglutinin variants |
ES2662778T3 (es) | 2009-09-22 | 2018-04-09 | Medicago Inc. | Método de preparación de proteínas derivadas de plantas |
CN102095852A (zh) * | 2010-11-24 | 2011-06-15 | 中国检验检疫科学研究院 | 一种用于快速检测新型h1n1流感病毒的双抗体夹心法 |
TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
NZ622731A (en) * | 2011-09-30 | 2016-04-29 | Medicago Inc | Increasing virus-like particle yield in plants |
JP6431477B2 (ja) | 2012-05-10 | 2018-12-05 | マサチューセッツ インスティテュート オブ テクノロジー | インフルエンザの中和のための薬剤 |
NZ704188A (en) * | 2012-07-17 | 2016-04-29 | Merial Inc | Attenuated swine influenza vaccines and methods of making and use thereof |
KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
CN104491463A (zh) * | 2014-11-18 | 2015-04-08 | 四川金堂海纳生物医药技术研究所 | 一种治疗舌溢血(舌衄)的汤剂药物及制备方法 |
WO2016090297A1 (en) * | 2014-12-04 | 2016-06-09 | The New York Stem Cell Foundation | Perfusion bioreactor |
JOP20190088A1 (ar) * | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
US20180128545A1 (en) * | 2016-11-08 | 2018-05-10 | Berry Metal Company | Modular furnace cooling wall |
US11918641B2 (en) | 2020-05-08 | 2024-03-05 | Academia Sinica | Chimeric influenza vaccines |
TW202334429A (zh) | 2021-10-01 | 2023-09-01 | 中央研究院 | Sars-cov-2棘蛋白特異性抗體及其用途 |
CN117229370A (zh) * | 2022-06-08 | 2023-12-15 | 中科南京生命健康高等研究院 | H5n6禽流感广谱性疫苗的开发及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
EP0974660A1 (en) | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
IL127331A0 (en) | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
US8475806B2 (en) * | 2003-05-28 | 2013-07-02 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
CN1261564C (zh) * | 2003-12-02 | 2006-06-28 | 中国农业科学院哈尔滨兽医研究所 | 人工重组的流感病毒及其应用 |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
-
2006
- 2006-07-27 US US11/460,584 patent/US7871626B2/en active Active
- 2006-07-28 KR KR1020087005408A patent/KR101334047B1/ko active IP Right Grant
- 2006-07-28 CA CA2617483A patent/CA2617483C/en active Active
- 2006-07-28 HU HUE06813248A patent/HUE043952T2/hu unknown
- 2006-07-28 CN CN201310049997.5A patent/CN103172710B/zh active Active
- 2006-07-28 CN CN2006800372900A patent/CN101283099B/zh active Active
- 2006-07-28 SG SG2014007934A patent/SG2014007934A/en unknown
- 2006-07-28 AU AU2006278696A patent/AU2006278696B2/en active Active
- 2006-07-28 BR BRPI0614297-4A patent/BRPI0614297A2/pt not_active Application Discontinuation
- 2006-07-28 RU RU2011103648/10A patent/RU2480480C2/ru active
- 2006-07-28 ES ES06813248T patent/ES2728791T3/es active Active
- 2006-07-28 RU RU2008107875/10A patent/RU2420535C2/ru active
- 2006-07-28 PL PL06813248T patent/PL1924281T3/pl unknown
- 2006-07-28 UA UAA200802674A patent/UA94717C2/ru unknown
- 2006-07-28 WO PCT/US2006/029575 patent/WO2007019094A2/en active Application Filing
- 2006-07-28 JP JP2008525063A patent/JP5395430B2/ja active Active
- 2006-07-28 EP EP06813248.9A patent/EP1924281B1/en active Active
-
2008
- 2008-01-17 ZA ZA200800505A patent/ZA200800505B/xx unknown
-
2010
- 2010-12-09 US US12/964,491 patent/US8293247B2/en active Active
-
2012
- 2012-09-13 US US13/614,835 patent/US8574592B2/en active Active
-
2013
- 2013-01-11 RU RU2013101020/10A patent/RU2552213C2/ru active
- 2013-09-04 JP JP2013183196A patent/JP5745584B2/ja active Active
- 2013-10-03 US US14/045,097 patent/US9499850B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94717C2 (ru) | Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины | |
ES2563646T3 (es) | Composiciones y métodos relacionados con variantes de la proteína A (SpA) | |
NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
EP1856271A4 (en) | INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS | |
ATE461710T1 (de) | Nipah-virus-impfstoffe | |
DE602006020032D1 (de) | Il-21-varianten | |
MX2011000437A (es) | Variantes de hemaglutinina y neuramnidasa de influenza. | |
RS53455B (en) | OPTIONS DERIVED FROM ActRIIB AND THEIR USE | |
RS53723B1 (en) | HUMAN VIRUS VIRUS, ASSOCIATED WITH ITS PREPARATION AND PROCEDURES | |
HRP20090245T1 (en) | Pyy agonists and uses thereof | |
DK1968632T3 (da) | Forbedret influenzavaccine | |
EA201491754A1 (ru) | Вакцина против rsv | |
CL2012000119A1 (es) | Polipeptido f de virus respiratorio sincicial recombinante, composicion inmunogenica que lo comprende, uso para la preparacion de un medicamento para la profilaxis contra dicho virus. | |
PE20142330A1 (es) | Vacuna de peptido ch3 de ige | |
MXPA05009580A (es) | Vacuna contra el virus de la influenza. | |
ES2575906T3 (es) | Composiciones y métodos de producir metionina | |
ATE554789T1 (de) | Neues hundeinfluenza-virus und imfpstoff hierfür | |
BR112014000466A2 (pt) | polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos | |
WO2009026465A3 (en) | Composition and methods of making and using influenza proteins | |
WO2011019932A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
BRPI0606189A2 (pt) | composição, vacina e método para proteger um animal porcino de infecção por um vìrus de prrs, célula hospedeira transfectada, método para fazer um vìrus de prrs geneticamente modificado e atenuado | |
EA201001045A1 (ru) | Модифицированный вирус гриппа | |
NZ594268A (en) | Grass peptides for vaccine | |
TW200733972A (en) | Compositions and methods for the treatment of canine influenza virus disease | |
NZ602380A (en) | Peptides for vaccine against birch allergy |